Vantive, Baxter International’s former kidney care segment, announced Monday it plans to invest more than $1 billion in new ...

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the global launch of PrisMax 2, the latest version of the company’s next ...

It’s called PRISMAX, and it’s now sold in six stores throughout the South Bay. And that’s only the beginning. “My dream?” said Robbie, who showed up to this interview wearing a three ...

SAN DIEGO--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced it has submitted the PrisMax system for 510(k) clearance to the U.S. Food and ...

will be the first in the U.S. to deploy the PrisMax technology system to treat ICU patients with acute kidney injury. The PrisMax platform, which was designed based on input from more than 650 ...

Baxter International Inc. BAX recently announced that Hamilton Health Care System will now be the first health system in the United States to utilize the former’s new PrisMax system. This new ...

Baxter International Inc. BAX recently announced the global launch of the latest version of its next-generation platform, PrisMax 2. The PrisMax 2 system aims to help streamline the delivery of ...

In parallel to its clinical trial, the Company continues to work closely with its commercialization partner, Vantive US Healthcare LLC ("Vantive”); and most recently the parties collaborated on ...

PrisMax 2 is designed to help simplify delivery of continuous renal replacement therapy (CRRT) and other organ support therapies, while providing hospitals the flexibility to meet the unique ...